Kết quả tìm kiếm - Martin van Cleeff

  • Đang hiển thị 1 - 4 kết quả của 4
Tinh chỉnh kết quả
  1. 1
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults Bằng Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Kathrin U. Jansen, Deepthi Jayawardene, Carmel Devlin, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

    Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent... Bằng Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Robert W. Frenck, John Treanor, Kathrin U. Jansen, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

    Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults Bằng Robert W. Frenck, Alejandra Gurtman, John Rubino, William Smith, Martin van Cleeff, Deepthi Jayawardene, Peter C. Giardina, Emilio A. Emini, William C. Gruber, Daniel A. Scott, Beate Schmöele-Thoma

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

    Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial Bằng Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Neil J. Fraser, Gigi Lefebvre, Mark G. Martens, Richard Mills, Richard Nathan, Miguel Á. Treviño, Martin van Cleeff, Ginamarie Foglia, Ayca Ozol-Godfrey, Dhaval M. Patel, Patricia J. Freda Pietrobon, Richard Gesser

    Được phát hành 2016
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: